Pharma Mar SA (PHM1N) Q3 2021 Earnings Report
MX:PHM1N Q3 2021 EPS Results
- Actual EPS
- MXN 13.26
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- MXN 19.66
MX:PHM1N Q3 2021 Revenue Results
- Actual Revenue
- MXN 952.57M
- Expected Revenue
- MXN 507.22M
- Beat/Miss
- Beat by +MXN 445.35M
- YoY Revenue Growth
- -14.70%
Earnings Announcement Details
- Quarter
- Q3 2021
- Date
- 10/28/2021
- Time
- TBA
- Conference Call
- Thursday, October 28, 2021
MX:PHM1N Upcoming Earnings
Pharma Mar SA's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q3 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:PHM1N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | 20.69- | 70.21 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 2.679.89 | -2.74 | 461.54% (+12.63) | |
| Jul 29, 2026 | 2026 (Q2) | 3.75-1.26 | 27.89 | -104.53% (-29.16) | |
| Apr 23, 2026 | 2026 (Q1) | 2.631.89 | -2.32 | 181.82% (+4.21) | |
| Feb 27, 2026 | 2025 (Q4) | 64.6370.21 | 22 | 219.14% (+48.21) | |
| Oct 30, 2025 | 2025 (Q3) | -3.26-2.74 | 4.21 | -165.00% (-6.95) | |
| Jul 30, 2025 | 2025 (Q2) | 0.6327.89 | 1.37 | 1938.46% (+26.52) | |
| Apr 24, 2025 | 2025 (Q1) | 6.63-2.32 | 2.53 | -191.67% (-4.84) | |
| Feb 28, 2025 | 2024 (Q4) | 20.4222.00 | -8 | 375.00% (+30.00) | |
| Oct 29, 2024 | 2024 (Q3) | 4.324.21 | 1.68 | 150.00% (+2.53) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed